clinical trials
Clinical trials for drugs, devices and other treatments or interventions
-
In a move that could drastically help slow the progression of Alzheimer's Disease (AD), the FDA has cleared C2N Diagnostics' PrecivityAD2 blood test for patients as young as 40 years who have shown potential cognitive symptoms of the condition.
-
A highly anticipated drug trial is in its final stages as its 350 participants receive their single dose to treat chronic low back pain. If successful, it could be a breakthrough therapeutic for people with the debilitating age-related condition.
-
In somewhat of a surprise announcement, the Food and Drug Administration has approved the first US influenza vaccine engineered from the mRNA technology that gave us one of the most administered COVID-19 shots during the pandemic.
-
A landmark study is due to start in the coming months, and if successful it could ultimately revive our immune system in older age and even treat chronic illnesses like autoimmune disease. The Phase 1 trial is aiming to rejuvenate senescent T cells.